Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|9|5|368-374

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.9, Iss.5, 2009-01, pp. : 368-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer vaccines entering Phase III clinical trials

By Durrant LG   Spendlove I  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite

Current Evidence from Phase III Clinical Trials of Selenium Supplementation in Critically Ill Patients: Why Should We Bother?

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 7, 2007-07 ,pp. : 693-699

Bentham Science Publishers

Access to resources Recommend Favorite

Electroporation Gene Therapy Preclinical and Clinical Trials for Melanoma

By  

Current Gene Therapy, Vol. 10, Iss. 4, 2010-08 ,pp. : 312-317

Bentham Science Publishers

Access to resources Recommend Favorite

Group-Sequential Methods for Adaptive Seamless Phase II/III Clinical Trials

By Stallard Nigel  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 787-801

Taylor & Francis Ltd

Access to resources Recommend Favorite

Understanding Site Performance Differences in Multinational Phase III Clinical Trials

By Glass Harold E.   DiFrancesco Jeffrey J.  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 4, 2007-01 ,pp. : 279-286

Adis International

Access to resources Recommend Favorite